Delhi HC reprimands DCGI after portions of CDSCO drug approval process report found missing
The court also directed DCGI to file a status report with regard to the steps taken by it to digitize its records, saying "there is no reason why DCGI should not digitize its records".;
New Delhi: The Delhi High Court on Wednesday pulled up the Drugs Controller General of India (DCGI) over portions of a report going missing with regard to procedures and practices followed by the Central Drugs Standard Control Organisation (CDSCO) while granting approvals to clinical trials of certain drugs, saying it was "really shocking" and "not a laughing matter".
"This is not a laughing matter. It is a very serious matter. I cannot allow this to go so easily. It is really really shocking. How can you say that annexures of a committee report placed before Parliament is not available with you," Justice Prathiba M Singh asked the DCGI.
The court was hearing a plea by an RTI applicant -- Prashant Reddy T -- who had made several attempts to obtain a copy of the report by the Dr T N Mahapatra Committee, which was constituted to review the procedures and practices followed by CDSCO for granting approval to clinical trials of certain drugs, and when the same was not provided in entirety to him, he had moved the High Court for production of the same.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.